Government moves to reduce the cost of PBS medicines 20 March 2025 The Federal Government has today announced that medicines on the Pharmaceutical Benefits Scheme (PBS) will cost no more than $25 from 1 January 2026. In a pre-election commitment that has been matched by the Federal Opposition, the maximum cost of a PBS prescription will drop from $31.60 to $25. Diabetes Australia Group CEO Justine Cain welcomed the announcement saying people taking diabetes medicines listed on the PBS will benefit from this cost of living relief. “A person’s bank balance or postcode should not be a barrier to good health. We must ensure medicines are affordable for people who need them. “Last year Diabetes Australia undertook a cost of living survey which showed that for 61% of people, the cost of diabetes medicines and technologies was their greatest challenge. “Lowering the cost of PBS medicines will help our community with the considerable strain of living with a chronic condition,” Ms Cain said. Diabetes medicines included in the price change include Metformin, Semaglutide, Empagliflozin, Dapagliflozin, and Empagliflozin with metformin. The Federal Government said the investment will cost $689 million over four years and the changes would come into effect on 1 January 2026 in line with regular indexation.
Media releases 17 October 2025 Free Shane Warne Legacy health check stations at the Geelong Show Free Shane Warne Legacy health checks are being provided at the Royal Geelong Show (16 – 19 October 2025) for... Continue Reading
Media releases 13 October 2025 My Health Record upgrades improving integrated care Faster access to more health data on My Health Record will benefit Australians living with diabetes. The Australian Digital... Continue Reading
Blog 22 September 2025 Care for your eyes People with diabetes have an increased risk of developing eye problems. Discover the long and short-term eye problems to keep a look out for. Continue Reading